BTG dropped thru' the floor on Friday due to the U.S. regulators suspending a clinical trial of its biggest new drug hope, an treatment for varicose veins...
Shares went from 380p to 154p in half an hour.
Wasn't 2 weeks ago that Investors Chronicle was predicting 700p & a 'STRONG BUY'(based on this new vaicose vein treatment launch, of course)..

Just wondering....at 154p, is it a good time to get in? I've got no idea how the US regulators work, but 'suspending' a trial doesn't sound too final to me!
Any opinions would be appreciated

VAS, well done you called it right. I stayed out and am cursing myself now.

cheers GF.

covered +17 :-)